Yamashita H - Search Results

1

Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.

Yamamoto Y, Masuda N, Ohtake T, Yamashita H, Saji S, Kimijima I, Kasahara Y, Ishikawa T, Sawaki M, Hozumi Y, Iwase H. Yamamoto Y, et al. Among authors: yamashita h. Breast Cancer. 2010 Oct;17(4):254-60. doi: 10.1007/s12282-009-0148-2. Epub 2009 Aug 15. Breast Cancer. 2010. PMID: 19685269

2

Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancer.

Moriyama S, Nakashima Y, Yano M, Kaji M, Yamakawa Y, Toyama T, Yamashita H, Iwase H, Sasaki H, Saito Y, Kiriyama M, Kato J, Fujii Y. Moriyama S, et al. Among authors: yamashita h. Jpn J Cancer Res. 2002 Jul;93(7):783-8. doi: 10.1111/j.1349-7006.2002.tb01320.x. Jpn J Cancer Res. 2002. PMID: 12149144 Free PMC article.

3

Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast.

Zhang Z, Yamashita H, Toyama T, Hara Y, Omoto Y, Sugiura H, Kobayashi S, Harada N, Iwase H. Zhang Z, et al. Among authors: yamashita h. Breast Cancer Res Treat. 2002 Jul;74(1):47-53. doi: 10.1023/a:1016022314608. Breast Cancer Res Treat. 2002. PMID: 12150452

4

Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y. Toyama T, et al. Among authors: yamashita h. Cancer Lett. 2003 Jan 10;189(1):97-102. doi: 10.1016/s0304-3835(02)00463-9. Cancer Lett. 2003. PMID: 12445683

5

The role of Stat5 in estrogen receptor-positive breast cancer.

Yamashita H, Iwase H. Yamashita H, et al. Breast Cancer. 2002;9(4):312-8. doi: 10.1007/BF02967610. Breast Cancer. 2002. PMID: 12459712

6

Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women.

Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Haruki N, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: yamashita h. Breast Cancer. 2003;10(1):70-3. doi: 10.1007/BF02967628. Breast Cancer. 2003. PMID: 12525766

7

Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.

Yamashita H, Iwase H, Toyama T, Fujii Y. Yamashita H, et al. Oncogene. 2003 Mar 20;22(11):1638-52. doi: 10.1038/sj.onc.1206277. Oncogene. 2003. PMID: 12642867

8

Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.

Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S. Iwase H, et al. Among authors: yamashita h. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S34-8. doi: 10.1007/s00280-003-0592-1. Epub 2003 Jun 19. Cancer Chemother Pharmacol. 2003. PMID: 12819932

9

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.

Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: yamashita h. Breast Cancer Res. 2003;5(6):R250-6. doi: 10.1186/bcr657. Epub 2003 Oct 9. Breast Cancer Res. 2003. PMID: 14580261 Free PMC article.

10

p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain.

Toyama T, Iwase H, Yamashita H, Hara Y, Sugiura H, Zhang Z, Fukai I, Miura Y, Riabowol K, Fujii Y. Toyama T, et al. Among authors: yamashita h. J Steroid Biochem Mol Biol. 2003 Oct;87(1):57-63. doi: 10.1016/s0960-0760(03)00388-1. J Steroid Biochem Mol Biol. 2003. PMID: 14630091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,593 results

Search Page

Filters